Why Europe is losing ground in clinical research
Europe has no shortage of data, so why does so much clinical research still struggle to reach patients?
What if the real barrier isn’t technology at all, but connection, readiness, and trust at scale?
This article explores why Europe’s vast clinical data remains under‑used, how fragmented systems limit access, and what it really takes to turn ethical rigor and governance into a competitive advantage for research, without losing what makes European healthcare trustworthy.
Understanding
the fragmentation
How inconsistent data access and operational complexity are limiting research performance across Europe.
Unlocking
patient access
Why recruitment remains the biggest bottleneck— and what it costs patients, sites and sponsors.
Building connected
capabilities
How trusted, interoperable systems create the foundations for research readiness at scale.
never heard of a study that concerned them personally,
a therapy that did not reach someone in time, a voice
that never entered the scientific evidence.
Download the White Paper
"*" indicates required fields